Development of AntiRetroviral Therapy in Africa (DART) study post hoc safety data analysis comparing safety outcomes of study participants with baseline creatinine clearance of 30-49 mL/min vs participants with creatinine clearance of ≥50 mL/min First published 18/06/2018 Last updated 02/04/2024 EU PAS number:EUPAS24473 Study Finalised